Deutsche Bank’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.32M | Buy |
|
|||||
|
2025
Q2 | $1.21M | Buy |
|
|||||
|
2025
Q1 | $1.09M | Sell |
|
|||||
|
2024
Q4 | $1.47M | Buy |
|
|||||
|
2024
Q3 | $934K | Buy |
|
|||||
|
2024
Q2 | $824K | Buy |
|
|||||
|
2024
Q1 | $808K | Buy |
|
|||||
|
2023
Q4 | $773K | Buy |
|
|||||
|
2023
Q3 | $457K | Buy |
|
|||||
|
2023
Q2 | $386K | Sell |
|
|||||
|
2023
Q1 | $591K | Buy |
|
|||||
|
2022
Q4 | $547K | Buy |
|
|||||
|
2022
Q3 | $618K | Sell |
|
|||||
|
2022
Q2 | $523K | Sell |
|
|||||
|
2022
Q1 | $471K | Sell |
|
|||||
|
2021
Q4 | $1.25M | Buy |
|
|||||
|
2021
Q3 | $385K | Buy |
|
|||||
|
2021
Q2 | $479K | Buy |
|